{"id":"W4409001910","doi":"10.1016/s1556-0864(25)00537-4","title":"345TiP: A phase I dose escalation/expansion study of GSK5764227 (GSK’227), a B7-homologue 3 (B7-H3) protein-targeted antibody-drug conjugate (ADC), in combination with standard of care (SoC), in patients with advanced solid tumours, including lung cancers","year":2025,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Ottawa Hospital","funders":"Merck Sharp and Dohme; Gilead Sciences","keywords":"Medicine; Conjugate; Standard of care; Antibody-drug conjugate; Antibody; Drug; Cancer research; Pharmacology; Oncology; Internal medicine; Monoclonal antibody; Immunology; Mathematical analysis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007351264,0.00108007,0.001079692,0.0004677822,0.0002612885,0.0008869873,0.0006796657,0.0009335335,0.00583589],"category_scores_gemma":[0.0005519121,0.0004881374,0.001177983,0.0003916383,0.0007002118,0.0006714647,0.0002914137,0.003682622,0.001500994],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007409313,"about_ca_system_score_gemma":0.001011329,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001084925,"about_ca_topic_score_gemma":0.002534289,"domain_scores_codex":[0.99979,0.00006374243,0.000009862961,0.00004077341,0.00002889854,0.00006669723],"domain_scores_gemma":[0.9997466,0.00003467601,0.00003304955,0.00002627647,0.00002227594,0.0001370955],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3444634,0.08955012,0.007873578,0.00227626,0.002619994,0.0006193045,0.0007140525,0.009138476,0.1724467,0.001768441,0.02488306,0.3436465],"study_design_scores_gemma":[0.4652058,0.4879911,0.01469047,0.0000881942,0.0009578453,0.000729539,0.0001424976,0.003581173,0.01493787,0.0006086496,0.01100033,0.00006652005],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9874495,0.002272813,0.001078909,0.0007707418,0.0002102328,0.001930205,0.001633811,0.0003766792,0.004277143],"genre_scores_gemma":[0.9837186,0.002212008,0.002437708,0.001246855,0.00009943569,0.001430019,0.00409385,0.00006801799,0.004693414],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00583589,"threshold_uncertainty_score":0.01952302,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008450471555992288,"score_gpt":0.4182881550432056,"score_spread":0.4098376834872133,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}